BCYRN1 and Alzheimer disease: The plasma levels of lncRNAs BC200 and NEAT1 were found to be significantly higher in late onset AD patients than healthy controls [21], suggesting these lncRNAs can be used for identifying and tracking the progression of late-onset AD.